BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27279087)

  • 1. Undetected lymph node metastases in presumed early stage NSCLC SABR patients.
    Cerra-Franco A; Diab K; Lautenschlaeger T
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):869-75. PubMed ID: 27279087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.
    Robson JM; Vaidyanathan S; Cheyne L; Snee M; Franks K; Callister ME
    Clin Lung Cancer; 2014 Nov; 15(6):466-9. PubMed ID: 25220208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
    Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
    Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients.
    Vial MR; Khan KA; O'Connell O; Peng SA; Gomez DR; Chang JY; Rice DC; Mehran R; Jimenez CJ; Grosu HB; Ost DE; Eapen GA
    Ann Thorac Surg; 2017 May; 103(5):1600-1605. PubMed ID: 28027732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Xu X; Yue J; Sun X; Hu X; Chen M; Xu W; Chen L; Yu J
    Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR).
    Dhaliwal I; Kassirian S; Mitchell MA; Qiabi M; Warner A; Louie AV; Wong HH; McDonald CM; Rajchgot J; Palma DA
    BMC Cancer; 2022 Apr; 22(1):468. PubMed ID: 35484614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
    Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
    Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
    Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
    Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
    Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
    Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    Verma V; Schonewolf CA; Cushman TR; Post CM; Doms A; Berman AT; DeVries M; Katz SI; Simone CB
    Clin Lung Cancer; 2018 Nov; 19(6):502-510. PubMed ID: 30111509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment.
    Nakajima T; Yasufuku K; Nakajima M; Baba M; Yoshikawa K; Kamada T; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
    J Thorac Oncol; 2010 May; 5(5):606-11. PubMed ID: 20354458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
    Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
    Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer - Results from a Single Institution Study.
    George B; Baydoun A; Bhat S; Bailey L; Arsenault T; Sun Y; Zhang Y; Zheng Y; Vempati P; Podder T; Biswas T
    Clin Lung Cancer; 2024 Jun; 25(4):e181-e188. PubMed ID: 38553326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic.
    Li L; Ren S; Zhang Y; Guan Y; Zhao J; Liu J; Wang Q; Chen G; Chen H; Xiang J; Fu X
    Lung Cancer; 2013 Aug; 81(2):213-7. PubMed ID: 23664030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
    Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
    Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognositc significance of SUV
    Dong M; Liu J; Sun X; Xing L
    J Med Imaging Radiat Oncol; 2017 Oct; 61(5):652-659. PubMed ID: 28266166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.